<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5270">
  <stage>Registered</stage>
  <submitdate>11/04/2015</submitdate>
  <approvaldate>11/04/2015</approvaldate>
  <nctid>NCT02417532</nctid>
  <trial_identification>
    <studytitle>Safety and Feasibility Evaluation of Robot Assisted Physiotherapy Exercises With REX</studytitle>
    <scientifictitle>Safety and Feasibility Evaluation of Robot Assisted Physiotherapy Exercises With REX</scientifictitle>
    <utrn />
    <trialacronym>SAFE RAPPER</trialacronym>
    <secondaryid>RXPR-0001</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Spinal Cord Injury</healthcondition>
    <conditioncode>
      <conditioncode1>Injuries and Accidents</conditioncode1>
      <conditioncode2>Fractures</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Injuries and Accidents</conditioncode1>
      <conditioncode2>Other injuries and accidents</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Rehabilitation using REX

Experimental: Rehabilitation using REX - Exercises using Rex mobility assist device


Treatment: devices: Rehabilitation using REX
Exercises of wheelchair dependent subjects using REX

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Completion of Transfer - Completion of transfer from wheelchair or bed to REX device</outcome>
      <timepoint>1 day</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Completion of REXercise 1 - Bilateral Shoulder Abduction</outcome>
      <timepoint>1 day</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Completion of REXercise 2 - Lateral Trunk Extension</outcome>
      <timepoint>1 day</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Adverse Events - absence of unexpected serious adverse events</outcome>
      <timepoint>1 day</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>User Transfer, in First Use - Ability to transfer to Rex in first use of device</outcome>
      <timepoint>1 day</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Competency of User, in First Use, in Autonomous Control of the Device in &lt;10 Minutes - Competent ability of user to use device within the first 10 Minutes without assistance</outcome>
      <timepoint>1 Day</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Participant Satisfaction Questionnaire - overall user satisfaction with the device</outcome>
      <timepoint>1 Day</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Timed up and go Test- Ability to Stand From Chair - Walk 3 m and turn around and walk back to the chair. (Functional test)</outcome>
      <timepoint>1 Day</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Inclusion Criteria

          -  Wheelchair user

          -  Spinal Injury Levels of C4 down to L5

          -  Has no outstanding skin integrity issues that could be effected by the REX device

          -  Should be between approximately 1.42m and 1.93m in height. More specifically, REX is
             able to accommodate the following limb lengths:

          -  Upper leg length : 380 - 470 mm

          -  Lower leg length : 366 - 470 mm

          -  Heel position (Ankle to hind foot) : 40 - 92 mm

          -  Floor to ankle height (To be measured while wearing the shoe to be used for mobilising
             in REX) : 96 - 116 mm

          -  Has a skeletal hip width of 380 mm or less (limit imposed by REX)

          -  Is between 40 kg and 100 kg weight (limits imposed by REX)

          -  Has the manual dexterity to work a joystick

          -  Sufficient passive range of motion in the Hip, Knee and Ankle of at least

          -  Hip 90 degrees flexion 15 degrees hip extension 20 degrees abduction 16 degrees
             adduction

          -  Knee 0 degrees extension 93 degrees flexion

          -  Ankle 20 degrees dorsiflexion (with weight bearing and 10 degrees knee flexion) 22
             degrees dorsiflexion (with 93 degrees knee flexion) 10 degrees plantar flexion 9
             degrees inversion 9 degrees eversion

          -  Thigh lateral diameter of &lt; 135 mm (230 mm above the knee joint line)

          -  Calf lateral diameter of &lt; 100 mm (90 mm below the knee joint line)

          -  Manual dexterity to work a joystick with or without a T-Bar and use emergency stop
             button

          -  No contraindications to standing or mobilising

          -  Patients must choose to participate, and must have signed the informed consent
             document</inclusivecriteria>
    <inclusiveminage>10</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>90</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Patients who do not meet inclusion criteria or physician discretion.

          -  Patients with history of impaired cardiac function who have been referred to and
             reviewed by a medical professional. With a decision made that they should not continue
             in the trial due to their impaired cardiac function.

          -  Patients contraindicated to walk or stand

          -  Patients with spinal injury outside Inclusion criteria

          -  Withdrawal or refusal to sign informed consent

          -  Any other contraindication based on physician discretion

          -  Known allergy (skin contact) to materials used in Rex</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Supportive Care</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/05/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>57</actualsamplesize>
    <recruitmentstatus>Terminated</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/12/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Austin Health - Heidelberg</hospital>
    <postcode>3084 - Heidelberg</postcode>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Christchurch</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Kent</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Middlesex</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Northamptonshire</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Rex Bionics Plc</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Commercial sector/Industry</othercollaboratortype>
      <othercollaboratorname>Generic Devices Consulting, Inc.</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Prospective, Open label, single arm, non-randomized, non-comparative registry study of
      Robot-Assisted Physiotherapy Exercises with the REX Robot powered exercise system in patients
      with Spinal cord or other injury preventing unsupported patient ambulation.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02417532</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Nicholas C Birch, FRCS</name>
      <address>The Chris Moody Centre</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>